FRESENIUS MEDICAL CARE AG (1FME.MI) Stock Fundamental Analysis
BIT:1FME - Euronext Milan - DE0005785802 - Common Stock - Currency: EUR
1FME gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 26 industry peers in the Health Care Providers & Services industry. 1FME has only an average score on both its financial health and profitability. 1FME has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year 1FME was profitable.
In the past year 1FME had a positive cash flow from operations.
In the past 5 years 1FME has always been profitable.
1FME had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.60%, 1FME is doing worse than 61.54% of the companies in the same industry.
1FME's Return On Equity of 3.69% is in line compared to the rest of the industry. 1FME outperforms 42.31% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.20%, 1FME is in line with its industry, outperforming 46.15% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1FME is below the industry average of 5.58%.
The 3 year average ROIC (3.14%) for 1FME is below the current ROIC(3.20%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.6% | ||
| ROE | 3.69% | ||
| ROIC | 3.2% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
The Profit Margin of 1FME (2.78%) is comparable to the rest of the industry.
1FME's Profit Margin has declined in the last couple of years.
The Operating Margin of 1FME (6.55%) is comparable to the rest of the industry.
1FME's Operating Margin has declined in the last couple of years.
1FME has a Gross Margin (24.60%) which is in line with its industry peers.
1FME's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.55% | ||
| PM (TTM) | 2.78% | ||
| GM | 24.6% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1FME is destroying value.
1FME has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1FME has less shares outstanding
The debt/assets ratio for 1FME has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.01 indicates that 1FME is not a great score, but indicates only limited risk for bankruptcy at the moment.
1FME has a Altman-Z score of 2.01. This is in the better half of the industry: 1FME outperforms 61.54% of its industry peers.
The Debt to FCF ratio of 1FME is 6.60, which is on the high side as it means it would take 1FME, 6.60 years of fcf income to pay off all of its debts.
1FME has a better Debt to FCF ratio (6.60) than 69.23% of its industry peers.
1FME has a Debt/Equity ratio of 0.67. This is a neutral value indicating 1FME is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.67, 1FME is doing good in the industry, outperforming 65.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 6.6 | ||
| Altman-Z | 2.01 |
ROIC/WACC0.57
WACC5.59%
2.3 Liquidity
A Current Ratio of 1.40 indicates that 1FME should not have too much problems paying its short term obligations.
1FME has a Current ratio of 1.40. This is in the better half of the industry: 1FME outperforms 61.54% of its industry peers.
1FME has a Quick Ratio of 1.03. This is a normal value and indicates that 1FME is financially healthy and should not expect problems in meeting its short term obligations.
1FME has a Quick ratio (1.03) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.4 | ||
| Quick Ratio | 1.03 |
3. Growth
3.1 Past
1FME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.66%, which is quite impressive.
The Earnings Per Share has been decreasing by -6.43% on average over the past years.
The Revenue has decreased by -0.61% in the past year.
1FME shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.04% yearly.
EPS 1Y (TTM)26.66%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%3.41%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%1.94%
3.2 Future
The Earnings Per Share is expected to grow by 9.10% on average over the next years. This is quite good.
Based on estimates for the next years, 1FME will show a small growth in Revenue. The Revenue will grow by 3.73% on average per year.
EPS Next Y14.77%
EPS Next 2Y12.67%
EPS Next 3Y13.51%
EPS Next 5Y9.1%
Revenue Next Year4.49%
Revenue Next 2Y4.19%
Revenue Next 3Y4.23%
Revenue Next 5Y3.73%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 12.57, 1FME is valued correctly.
1FME's Price/Earnings ratio is rather cheap when compared to the industry. 1FME is cheaper than 80.77% of the companies in the same industry.
1FME's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.51.
The Price/Forward Earnings ratio is 10.95, which indicates a very decent valuation of 1FME.
Based on the Price/Forward Earnings ratio, 1FME is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of 1FME to the average of the S&P500 Index (34.09), we can say 1FME is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.57 | ||
| Fwd PE | 10.95 |
4.2 Price Multiples
73.08% of the companies in the same industry are cheaper than 1FME, based on the Enterprise Value to EBITDA ratio.
61.54% of the companies in the same industry are cheaper than 1FME, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.41 | ||
| EV/EBITDA | 10.94 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1FME's earnings are expected to grow with 13.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.85
PEG (5Y)N/A
EPS Next 2Y12.67%
EPS Next 3Y13.51%
5. Dividend
5.1 Amount
1FME has a Yearly Dividend Yield of 3.41%. Purely for dividend investing, there may be better candidates out there.
1FME's Dividend Yield is a higher than the industry average which is at 3.00.
Compared to an average S&P500 Dividend Yield of 2.40, 1FME pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.41% |
5.2 History
The dividend of 1FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1FME pays out 64.91% of its income as dividend. This is not a sustainable payout ratio.
The dividend of 1FME is growing, but earnings are growing more, so the dividend growth is sustainable.
DP64.91%
EPS Next 2Y12.67%
EPS Next 3Y13.51%
BIT:1FME (8/7/2025, 7:00:00 PM)
40.84
-3.73 (-8.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners36.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.97B
Analysts66.15
Price Target47.48 (16.26%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.41% |
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP64.91%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.42%
Min EPS beat(2)15.03%
Max EPS beat(2)25.81%
EPS beat(4)4
Avg EPS beat(4)20.21%
Min EPS beat(4)2.71%
Max EPS beat(4)37.27%
EPS beat(8)6
Avg EPS beat(8)12.6%
EPS beat(12)8
Avg EPS beat(12)9.6%
EPS beat(16)12
Avg EPS beat(16)7.86%
Revenue beat(2)1
Avg Revenue beat(2)0.82%
Min Revenue beat(2)-4.4%
Max Revenue beat(2)6.05%
Revenue beat(4)2
Avg Revenue beat(4)-0.59%
Min Revenue beat(4)-4.95%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.53%
Revenue beat(12)5
Avg Revenue beat(12)-0.48%
Revenue beat(16)5
Avg Revenue beat(16)-0.62%
PT rev (1m)2.47%
PT rev (3m)17.04%
EPS NQ rev (1m)17.29%
EPS NQ rev (3m)N/A
EPS NY rev (1m)5.94%
EPS NY rev (3m)5.3%
Revenue NQ rev (1m)1.4%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.57 | ||
| Fwd PE | 10.95 | ||
| P/S | 1.24 | ||
| P/FCF | 14.41 | ||
| P/OCF | 10.04 | ||
| P/B | 1.64 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.94 |
EPS(TTM)3.25
EY7.96%
EPS(NY)3.73
Fwd EY9.13%
FCF(TTM)2.84
FCFY6.94%
OCF(TTM)4.07
OCFY9.96%
SpS32.95
BVpS24.84
TBVpS-3.35
PEG (NY)0.85
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.6% | ||
| ROE | 3.69% | ||
| ROCE | 4.54% | ||
| ROIC | 3.2% | ||
| ROICexc | 3.39% | ||
| ROICexgc | 9.15% | ||
| OM | 6.55% | ||
| PM (TTM) | 2.78% | ||
| GM | 24.6% | ||
| FCFM | 8.6% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexcg growth 3Y-7.67%
ROICexcg growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 6.6 | ||
| Debt/EBITDA | 3.25 | ||
| Cap/Depr | 41.46% | ||
| Cap/Sales | 3.74% | ||
| Interest Coverage | 3.32 | ||
| Cash Conversion | 79.32% | ||
| Profit Quality | 309.29% | ||
| Current Ratio | 1.4 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 2.01 |
F-Score6
WACC5.59%
ROIC/WACC0.57
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)26.66%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%3.41%
EPS Next Y14.77%
EPS Next 2Y12.67%
EPS Next 3Y13.51%
EPS Next 5Y9.1%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%1.94%
Revenue Next Year4.49%
Revenue Next 2Y4.19%
Revenue Next 3Y4.23%
Revenue Next 5Y3.73%
EBIT growth 1Y-8.56%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year103.45%
EBIT Next 3Y32.04%
EBIT Next 5Y17.68%
FCF growth 1Y-13.25%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y-9.23%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%